olmesartan has been researched along with tretinoin in 2 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (tretinoin) | Trials (tretinoin) | Recent Studies (post-2010) (tretinoin) |
---|---|---|---|---|---|
841 | 185 | 554 | 23,654 | 1,083 | 6,085 |
Protein | Taxonomy | olmesartan (IC50) | tretinoin (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
Amyloid-beta precursor protein | Homo sapiens (human) | 0.18 | |
Adenosine receptor A3 | Homo sapiens (human) | 5.275 | |
Retinoic acid receptor alpha | Homo sapiens (human) | 2.2542 | |
60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
Retinoic acid receptor beta | Homo sapiens (human) | 0.7537 | |
Retinoic acid receptor alpha | Mus musculus (house mouse) | 0.0057 | |
Retinoic acid receptor gamma | Homo sapiens (human) | 0.0064 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
Retinoic acid receptor gamma | Mus musculus (house mouse) | 0.004 | |
Retinoic acid receptor beta | Mus musculus (house mouse) | 0.005 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.576 | |
Nuclear receptor ROR-alpha | Homo sapiens (human) | 0.1995 | |
Alpha-synuclein | Homo sapiens (human) | 3 | |
Cellular retinoic acid-binding protein 1 | Gallus gallus (chicken) | 0.5233 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.358 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
Retinoic acid receptor RXR-gamma | Homo sapiens (human) | 0.35 | |
Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.1995 | |
10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | 0.82 | |
60 kDa chaperonin | Escherichia coli | 6.7 | |
10 kDa chaperonin | Escherichia coli | 6.7 | |
Nuclear receptor ROR-beta | Homo sapiens (human) | 0.1259 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
2 other study(ies) available for olmesartan and tretinoin
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |